NewsSeparations
Biopharmaceuticals Webinar Series: Solutions in Biopharmaceutical Discovery
Watch the award-winning webinar series by Agilent Technologies
8 Mar 2017
Sarah Thomas
Associate Editor
Expert insights
We were delighted to present Agilent Technologies with the Scientists’ Choice Award for Best Webinar Series of the Year for its Biopharmaceuticals Webinar Series: Solutions in Biopharmaceutical Discovery and Development. The webinar series ran for 10 episodes over the course of 2016 – watch the webinars below:
- Rapidly Characterize Antibody-Drug Conjugates and Derive Drug-to-Antibody Ratios Using LC/MS
- Biosimilars Workflow: Biocolumns
- 3-Part Series: Technology Accelerating Biopharma: Analytical Workflow Solutions
- Online 2D-LC Analysis of Complex N-Glycans in Biopharmaceuticals
- Enhancing the Mass Spectrometry Characterization of Antibody Drug Conjugates (ADCs)
- New Advances in Biotherapeutic Aggregate and Charge Variant Analysis
- Faster Aggregation Method Development with Cutting Edge LC Technology
- Rapid, Powerful Technologies to Address Peptide Mapping Challenges – A Comprehensive Workflow Solution from Sample to Answer
Learn more about the Scientists’ Choice Awards® presented at Pittcon 2017
Links
Tags
UHPLC and HPLCHigh performance liquid chromatography (HPLC) and ultra high performance liquid chromatography (UHPLC), also known as UPLC, are analytical techniques used to separate, identify and quantitate components of complex mixtures including biological samples such as proteins and lipids as well as chemical mixtures of pesticides, drugs and oils. Both techniques are liquid chromatographic methods but differ by operating pressures (HPLC < 6000 psi < UHPLC ). Components of HPLC and UHPLC systems include columns, detectors, pumps, autosamplers and column heaters. Explore a range of UHPLC and HPLC columns for your specific sample needs including reverse phase, normal phase, ion exchange, HILIC, ion exclusion and size exclusion columns. For more specialized HPLC, explore FPLC, countercurrent LC and simulated moving bed systems. Find the best UHPLC and HPLC equipment in our peer reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.LC-MSLC-MS (liquid chromatography-mass spectrometry) systems and equipment are used for separation and quantitative analysis of complex mixtures, combining liquid chromatography and mass spectrometry. Quantify proteins, contaminants, pesticides or screen for drug metabolites with a high level of sensitivity. LC-MS systems and equipment include reverse phase, normal phase and specialized columns integrated with various MS detectors such as time-of-flight (TOF), quadrupole, orbitrap or ion trap mass analyzers. LC-MS/MS instruments equipped with a qTOF or triple quadrupole analyzer give greater sensitivity and resolving power to your analysis. Find the best LC-MS equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.GlycansScientists Choice AwardsEach year, the SelectScience Scientists' Choice Awards celebrate the best products in the industry, as nominated and voted for by our scientist members.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.BiosimilarsBiosimilars are very similar versions of approved and authorized medicines. Clinically inactive components will have minor differences, but there are no significant differences between the biosimilar and the original product in terms of potency, purity and safety.Peptide MappingBiotherapeuticsBiotherapeutics are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or in <i>in vivo</i> diagnostics. The most well-known example of a biotherapeutic product, and the first to be approved for therapeutic use, was recombinant human insulin.